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Abstract
Background: Few studies have comprehensively described tropical respiratory disease surveillance in military
populations. There is also a lack of studies comparing clinical characteristics of the non-influenza pathogens with
influenza and amongst themselves.
Methods: From May 2009 through October 2012, 7733 consenting cases of febrile respiratory illness (FRI)
(temperature [greater than or equal to]37.5degreesC with cough or sorethroat) and controls in the Singapore
military had clinical data and nasal washes collected prospectively. Nasal washes underwent multiplex PCR, and the
analysis was limited to viral mono-infections.
Results: 49% of cases tested positive for at least one virus, of whom 10% had multiple infections. 53% of the FRI
cases fulfilled the definition of influenza-like illness (ILI), of whom 52% were positive for at least one virus. The most
frequent etiologies for mono-infections among FRI cases were Influenza A(H1N1)pdm09 (13%), Influenza B (13%)
and coxsackevirus (9%). The sensitivity, specificity, positive predictive value and negative predictive value of ILI for
influenza among FRI cases were 72%, 48%, 40% and 69% respectively. On logistic regression, there were marked
differences in the prevalence of different symptoms and signs between viruses with fever more prevalent amongst
influenza and adenovirus infections than other viruses.
Conclusion: There are multiple viral etiologies for FRI and ILI with differing clinical symptoms in the Singapore
military. Influenza and coxsackevirus were the most common etiology for FRI, while influenza and adenoviruses
displayed the most febrile symptoms. Further studies should explore these differences and possible interventions.
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Background
Influenza-like illness (ILI) is often used for influenza sur-
veillance [1], as influenza is a disease of global interest
with 5% of adults developing symptomatic disease annu-
ally and with case fatalities of 3.5% in susceptible popula-
tions [2]. While influenza surveillance remains a priority,
ILI can also be caused by a wide range of viral pathogens
that present with a spectrum of respiratory symptoms
[3-6]. In the tropics, viral respiratory pathogens have been
reported to exhibit different seasonality and transmission
characteristics compared to temperate climates [2,7-9].
This necessitates a better understanding of their epidemi-
ology to assess the utility and importance of surveillance
in these settings. The year-round circulation of respiratory
viruses in the tropics may also predispose patients to co-
infection with multiple pathogens, with implications for
severity of disease [10,11] and secondary bacteria infection
[12,13].
While there have been studies comparing differences in
clinical presentation between influenza and non-influenza
cases [14], few describe the epidemiology and differences
in clinical presentation among various non-influenza re-
spiratory viruses. As influenza viruses have accounted for
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only between 10.1% to 53.0% of all ILI cases [15-17], it is
important to understand the contribution of other respira-
tory pathogens to overall morbidity and to determine their
epidemiological distribution and clinical presentation.
To address these issues, this study explores data obtained
from a respiratory disease sentinel surveillance system in
the Singapore military to examine the etiologic viral agents
of respiratory illnesses in a tropical environment, to deter-
mine the viruses that circulate post-influenza vaccination,
and to compare the differences in clinical presentation.
Methods
Study site and population
Singapore is a city-state in tropical South-East Asia with
a population of 5.3 million people (mid-year 2012). The
Singapore military is based on national service in which
all male Citizens and liable Permanent Residents serve
for two years after high school. Servicemen typically live
in barracks-style accommodation on weekdays and re-
turn home on weekends.
The Singapore military started a sentinel respiratory
disease surveillance program in 5 major camps (including
a recruit training camp) on 11 May 2009, tracking febrile
respiratory illness (FRI) cases (temperature ≥37.5°C with
cough or sore throat). The definition of FRI contrasts
with influenza-like illness (ILI, defined as fever ≥38.0°C
with cough or sore throat) to broaden the capture of
other febrile cases that also result in absenteeism while
limiting cases to those with fever as an indicator of sever-
ity. This allows for detection of a larger number of re-
spiratory pathogens.
Patients who visited the primary healthcare clinics in
the camps between 11 May 2009 and 31 October 2012
during regular consultation hours who met the FRI cri-
teria were recruited. Healthcare workers obtained written
informed consent, administered a questionnaire, obtained
clinical specimens and performed a clinical examination
on partcipants. Repeat consultations were excluded if the
healthcare worker determined that the patient had not re-
covered from the first illness episode. We also obtained
samples from controls (those without respiratory symp-
toms or acute infections), who were recruited across the
year at between 5 to 10 persons per week. Informed con-
sent, the baseline questionnaire, and clinical specimens
were obtained.
From December 2009, all recruits were administered
with the Influenza A(H1N1)pdm09 (FLU-A(H1N1)pdm09)
vaccine. The trivalent seasonal influenza vaccination was
first introduced to recruits in December 2010, followed
henceforth by all other personnel in November 2011.
Laboratory methods
Nasal washes from each side of the nose were taken from
consenting participants by trained medical staff, placed
in viral transport media and refrigerated. The samples
were transported to the laboratory on ice for etiological
testing within 24 hours.
Laboratory analysis was performed in an ISO15189-
accreditated laboratory for molecular diagnostics which
regularly takes part in external proficiency programs such
as QCMD EQA programs. Detailed laboratory methods
were previously described [14]. We used the multiplex
PCR strategy based on the Resplex assays described
below, and performed additional singleplex PCR assays
to determine the influenza subtype. Total nucleic acids
were extracted from each specimen using the DNA mini-
kit (Qiagen, Inc, Valencia, CA, USA) according to manu-
facturer’s instructions. A total of 20 μl of extract were
tested with Resplex I and II (version 2.0, Qiagen, Inc.,
Valencia, CA, USA) [18] for respiratory micro-organisms
on the LiquiChip 200 Workstation, according to manu-
facturer’s instructions. The Resplex I and II (version 2.0)
assays are multiplex PCR assays coupled with bead array
detection technology and can simultaneously detect and
subtype 18 different pathogens including influenza A
(FLU-A) and influenza B (FLU-B). Specimens that were
Resplex II positive for FLU-A were further subtyped with
real-time PCR for H1 or H3 (Singapore Ministry of
Health), or for FLU-A(H1N1)pdm09. Briefly, 5 μl of total
genetic extracts were tested using an in-house developed
assay based on the one-step SuperscriptIII/Platinum Taq
kit (Invitrogen, Carlsbad, CA, USA) following manufac-
turer’s instructions on the LightCycler machine from
Roche or the Applied Biosystems real-time PCR machine
(7500).
Statistical methods
The analysis was limited to viral mono-infections amongst
cases to discern clinical presentations and symptom com-
plexes associated with each pathogen. We excluded vi-
ruses with fewer than 20 cases (0.6% of the total), as the
number was too small to have a reasonable sample size –
these were Coronavirus HKU1 (CoV-HKU1), Parainflu-
enza 1 (hPIV-1), hPIV-2, hPIV-4, Influenza A(H1N1) (the
prepandemic strain), respiratory syncytial virus A (RSV
A), RSV B, CoV and Bocavirus (BV). This left 14 viruses
for the subsequent analyses.
The main aim was to compare the differences in clinical
expressions, including individual symptoms (or signs),
pairs of symptoms, and overall symptom load between
patients with different viral infections. We counted the
clinical symptoms/signs and calculated the corresponding
empirical proportions with 95% confidence intervals (CIs)
to evaluate the overall symptom load. Logistic regression
analysis was used to investigate the differences in symp-
tom expressions for each pair. Differences were identified
at a significance level of 0.05. To assess the presence of
paired symptoms/signs for all viruses, we conducted
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binomial tests to compare the joint proportions of symp-
tom pairs occurring together to the expected proportions
assuming independence of symptoms. The ratio of the
observed proportion of symptom pairs relative to the
product of the marginal proportion of each symptom is
defined as the excess probability ratio which measures ef-
fect size. Multivariate logistic regression analysis was per-
formed to compare the risk of having an individual
symptom/sign among viral mono-infections by assigning
a categorical variable for all viruses as the primary pre-
dictor. Potential confounding was addressed by adjusting
the model for age, smoking status, asthma and heart dis-
ease. Non-significant variables were dropped at a signifi-
cance level of 0.05 to obtain the final model. Statistical
analyses were performed using the R Statistical Software
(version 3.0.0) [19].
Ethics approval was given by the Singapore military’s
Joint Medical Committee for Research, and the National
University of Singapore’s ethics review committee.
Results
The basic demographic data are described in Table 1.
Participants were mostly young male adults, with other
characteristics largely similar. However, there were sig-
nificantly less recruits amongst controls than amongst
other groups.
The temporal distribution of cases is described in
Figure 1. No obvious overall seasonal pattern can be ob-
served. The peak in June and July 2009 corresponds to
the FLU-A(H1N1)pdm09 pandemic [16]. As this peak
tailed off, we observed an increase in FLU-B cases (start-
ing Feb–Mar 2010). Subsequently, as the FLU-B cases
fell, Adenovirus E (ADV-E) cases started to increase.
Coxsackie/echovirus (CV) and rhinovirus (RV) infections
were consistently present in the earlier periods but ap-
peared to tail off by 2012, corresponding to the rise in
FRI cases due to other viruses.
The etiologies of selected infections are illustrated in
Table 2. At least one virus was detected in 3794 of the
7733 FRI cases (49.1%). In 376 (9.0%) of the 3794 cases,
more than one virus was detected and these were
excluded. 4120 (53.3%) of the FRI cases fulfilled the def-
inition of ILI; 2146 (52.1%) of these ILI cases were posi-
tive for at least 1 virus. Of the 3430 FRI mono-infection
cases, 2128 (62.0%) were viral. 1259 (59.2%) of these
2128 cases met the definition of ILI.
We examined the proportion of ILI cases among those
with viral mono-infections (Table 3). Influenza viruses
accounted for only 40% of ILI. Among FRI cases, more
than 60% of patients with influenza and adenovirus infec-
tions presented with ILI. However, several other viral in-
fections led to high rates of ILI, including CV, Human
Metapneumovirus (hMPV) and CoVs. The sensivity, spe-
cifity, positive predictive value (PPV) and negative pre-
dictive value (NPV) of ILI for influenza was 72.2%, 48.1%,
40.1% and 69.3% respectively.
On univariate comparison of clinical symptoms and
signs, Adenovirus B (ADV-B), as well as Influenza A
(H3N2) (FLU-A(H3N2)), FLU-A(H1N1)pdm09 and FLU-B
tended to cause fever more frequently (0.31 (95% CI:
0.14,0.48), 0.30 (0.21,0.40), 0.23 (0.17,0.28), 0.28 (0.22,0.33)).
ADV-E was inclined to cause less respiratory symptoms
(cough with phlegm, dry cough, running nose)(-0.08 (-0.17,
0.03), -0.26 (-0.37, -0.16), -0.18 (-0.28, -0.07)).
From the multivariate analysis (Figure 2), compared to
most other viruses, A FLU-A(H1N1)pdm09 and FLU-A
(H3N2) less commonly resulted in sorethroat. Running
nose was more common in enterovirus (EV) and RV cases
and less common in ADV. FLU-B was more likely than a
majority of the other viruses to cause dry cough while EV
and ADV-E were less likely to cause dry cough. CoV-
OC43 and hMPV were more likely to cause cough with
phlegm than the most other viruses. Influenza viruses and
adenoviruses were more likely to cause fever ≥38.0°C.
In Figure 3, we explored the associations (and dissocia-
tions) between different clinical symptoms and signs
across all viruses. Some are expected, such as association
of fever ≥37.8°C and fever ≥38.0°C and dissociation of
dry cough and cough with phlegm. Fever ≥38.0°C was
also associated with systematic complaints, such as chills,
bodyache, headache and eye pain. Sorethroat was associ-
ated with an injected pharynx.
Table 1 Demographics of all participants, cases, controls and mono-infection cases
Characteristics All (Count, %) Cases (Count, %) Controls (Count, %) Mono-infection (Count, %) p-value†
Age (Mean, SD) 20.8 (3.1) 20.7 (3.1) 21.1 (2.9) 20.7 (3.2) 0.781
Male 9055 (99.8) 7713 (99.7) 1342 (99.9) 3422 (99.8) 0.902
Current Smoker 2475 (27.3) 2090 (27.0) 385 (28.6) 887(25.9) 0.220
Recruit 3870 (42.6) 3627 (46.9) 243 (18.1) 1575 (45.9) <0.001
Asthma 1833 (20.2) 1597 (20.7) 236 (17.6) 721 (21.0) 0.051
Heart Disease 102 (1.1) 83 (1.1) 19 (1.4) 37 (1.1) 0.748
Total 9077 (100.0) 7733 (100.0) 1344 (100.0) 3430 (100.0) -
† By ANOVA test, comparing mean age, and by Pearson's chi-square test, comparing proportions across all categories.
Tan et al. BMC Infectious Diseases 2014, 14:204 Page 3 of 9
http://www.biomedcentral.com/1471-2334/14/204
Discussion
Our study shows the different viral etiologies of ILI and
compares the clinical characteristics of different viral eti-
ologies in a tropical setting. This data series only spanned
three years, and initial observations showed no clear sea-
sonal variation compared to temperate regions, similar to
previous reports of overall tropical respiratory disease
patterns [7,9,20]. The initial peak corresponded to the
FLU-A(H1N1)pdm09 pandemic [21], with the subse-
quent lower incidence in the recruit population likely
due to vaccination with the pandemic vaccine a year be-
fore annual seasonal vaccination was started across all
personnel [22].
The number of FRI cases remained fairly consistent
throughout the study period (except the pandemic).
However, prevalence of pathogens varied throughout,
with some negative correlation observed between the vi-
ruses – e.g. a drop in FLU-A followed by a rise in FLU-B
activity, and a drop in FLU-B cases followed by a rise in
adenovirus activity. Correlation of viral activity have pre-
viously been reported – Wang et al [23] reported nega-
tive association between RV and ADV rates, while Bellei
et al [15] and Razanajatovo et al [24] described concomi-
tant rise of influenza and RV, and influenza and ADV
activity respectively. In addition, Kasper et al reported
that ILI rates remained constant despite varying preva-
lences of influenza [25]. This supports our findings that
multiple agents are capable of causing ILI, and a decrease
in the prevalence of one virus was replaced by an in-
crease in prevalence of another. Further studies across a
longer time period are necessary, especially for vaccine
effectiveness evaluation.
49.1% of FRI and 52.1% of ILI cases were positive for a
virus, similar to the 44.5% and 61.8% reported by studies
targeting similar panel of organisms [3,6,15,17,26,27].
The remaining FRI cases may be due to non-viral agents,
agents beyond the ability of the test, non-infectious
causes, and possible sampling errors. Viruses most com-
monly detected in ILI cases were FLU-A, FLU-B, and CV
in that order. Influenza was also the top etiologic agent
for ILI in some studies [6,15,17,24,28] although other
pathogens have been identified to be most prevalent in
different settings, such as RSV and hMPV in France [29],
influenza and RSV in the USA [30], influenza and RV in
Central America [16] and China [6] and in Italy, influ-
enza and ADV [31]. The range of pathogens indicates
a need to perform local continual surveillance since
prevailing pathogens differ across different populations,
Figure 1 Distribution of weekly cases of febrile respiratory illness (FRI), viral mono-infections during study period*. *The top panel
presents the weekly FRI cases together with viral mono-infection cases. The second panel is a frequency chart presenting the weekly viral
mono-infection cases. The dominating virus was placed at the bottom of each bar. Viruses are shaded in different colors – Adenovirus E (ADV-E);
Influenza A(H3N2) (FLU-A(H3N2)); Rhinovirus (RV); Coxsackie/Echovirus (CV); Influenza B (FLU-B) and influenza A(H1N1)pdm09 (FLU-A(H1N1)
pdm09). Influenza A(H1N1) (FLU-A(H1N1) and Influenza (unknown type) (FLU-A(unknown)), Adenovirus B (ADV-B) and ADV(untyped), Enterovirus
(EV), human metapneumovirus (hMPV), Parainfluenza 1 (hPIV-1), hPIV-2, hPIV-3 and hPIV-4,Coronavirus OC43 (CoV-OC43), CoV-NL63, CoV-229E,
CoV-HKU1 and CoV(untyped), respiratory syncytial virus A (RSV-A) and RSV-B and Bocavirus (BV) are pooled as others in the bottom panel.
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geographic regions and climates. The high incidence of
CV warrants further study – hand, foot and mouth dis-
ease is endemic to Singapore and CV is frequently identi-
fied in pediatric samples [32], and it is possible that CV
circulates at high levels in adults also.
Previous studies have identified a co-infection rate of
11.0 to 47.0% [6,11,24,33,34] for viruses, higher than the
9.9% found in this study despite some studies using a
less extensive diagnostic panel in a similar age group.
Possible reasons include our highly influenza-vaccinated
population or a warmer climate with higher relative hu-
midity resulting in lower virus circulation [35] and a
study population that did not include children (studies
reported higher co-infection rates amongst pediatric pa-
tients [17,24]).
In both univariate and multivariate analysis, ADV and
influenza viruses were more likely to cause fever (≥38.0°C).
This finding has been demonstrated in other studies
[14,15,36-39]. Fever also tends to be associated with other
systemic complaints such as eye pain, bodyache and
headache; this may be due to cytokine mediated system-
atic inflammatory response [40] and could indicate more
severe disease. Bellei et al’s [15] study in Brazil also found
that EV, RV and CoV were least likely to cause fever, and
that RV and EV cases were the most likely to present with
rhinorrhea. Cough with sputum in FLU-A(H3N2) and
FLU-A were less prevalent than in other viruses, in con-
trast to reports in other settings [14,37-39]. We found
that FLU-B cases were more likely to report dry cough,
similar to other studies [14,37-39]. The heterogeneity of
Table 2 Etiology of by cases, controls and mono-infections
FRI Cases (n = 7733) Controls (n = 1344) Mono-infection (n = 3430†)
Virus No. of positives (%)
(n = 3794)
No. of ILIs positives
(%) (n = 2146)
No. of positives (%)
(n = 115)
No. of positives (%)
(n = 2128)
Coxsackie/Echovirus 708 (9.2) 318 (4.1) 37 (2.8) 324 (9.4)
Influenza B 604 (7.8) 449 (5.8) 7 (0.5) 441 (12.9)
Rhinovirus 574 (7.4) 220 (2.8) 24 (1.8) 257 (7.5)
Influenza A(H1N1)pdm09 568 (7.3) 393 (5.1) 3 (0.2) 459 (13.4)
Adenovirus E 516 (6.7) 317 (4.1) 9 (0.7) 100 (2.9)
Coronavirus OC43 235 (3.0) 103 (1.3) 10 (0.7) 83 (2.4)
Human Metapneumovirus 142 (1.8) 82 (1.1) 0 (0.0) 60 (1.7)
Influenza A(H3N2) 137 (1.8) 96 (1.2) 4 (0.3) 107 (3.1)
Parainfluenza 3 122 (1.6) 58 (0.8) 1 (0.1) 48 (1.4)
Adenovirus B 116 (1.5) 85 (1.1) 4 (0.3) 29 (0.8)
Enterovirus 109 (1.4) 42 (0.5) 4 (0.3) 35 (1.0)
Coronavirus NL63 62 (0.8) 31 (0.4) 0 (0.0) 34 (1.0)
Coronavirus 229E 61 (0.8) 26 (0.3) 6 (0.4) 30 (0.9)
Influenza A (Unknown type) 60 (0.8) 34 (0.4) 8 (0.6) 41 (1.2)
The following pathogens recorded less than 20 mono-infection cases each and were not included in the table: Coronavirus HKU1, Parainfluenza 1, 2 and 4,
Influenza A/H1, Respiratory Syncytial Virus A and B, Bocavirus.
† Of the 3430 mono-infection cases, there are 1904 ILI cases.
Table 3 Summary of virus mono-infections having
influenza-like illness (ILI), 11 May 2009 to 31 Oct 2012
Virus Probability of virus
given ILI (%)
(95% CI)
Probability of having ILI




16.7 (15.1 to 18.5) 69.3 (64.8 to 73.5)
Influenza A(H1N1) 0.4 (0.2 to 0.8) 80.0 (44.4 to 97.5)
Influenza A(H3N2) 4.2 (3.4 to 5.2) 74.8 (65.5 to 82.7)
Influenza A
(Unknown type)
1.4 (0.9 to 2.0) 63.4 (46.9 to 77.9)
Influenza B 17.4 (15.8 to 19.2) 75.3 (71.0 to 79.2)
Coxsackie/Echovirus 7.9 (6.7 to 9.2) 46.6 (41.0 to 52.2)
Enterovirus 0.5 (0.2 to 0.9) 25.7 (12.5 to 43.3)
Rhinovirus 5.1 (4.2 to 6.2) 37.7 (31.8 to 44.0)
Adenovirus B 1.4 (0.9 to 2.0) 89.7 (72.7 to 97.8)
Adenovirus E 3.4 (2.6 to 4.3) 65.0 (54.8 to 74.3)
Adenovirus 0.1 (0.0 to 0.3) 50.0 (1.3 to 98.7)
hMPV 1.9 (1.3 to 2.6) 60.0 (46.5 to 72.4)
Coronavirus 229E 0.6 (0.3 to 1.1) 40.0 (22.7 to 59.4)
Coronavirus HKU1 0.4 (0.2 to 0.8) 41.2 (18.4 to 67.1)
Coronavirus NL63 0.8 (0.5 to 1.4) 47.1 (29.8 to 64.9)
Coronavirus OC43 1.7 (1.2 to 2.4) 38.6 (28.1 to 49.9)
Coronavirus 0.0 (0.0 to 0.2) 0.0 (0.0 to 97.5)
Others† 2.3 (1.6 to 3.0) 43.9 (33.9 to 54.3)
Non-viral aetiologies accounted for 33.9% of the ILIs.
† RSV A, RSV B, Parainfluenza 1, Parainfluenza 2, Parainfluenza 3, Parainfluenza 4,
and Bocavirus are pooled as others.
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results across different studies highlight the difficulty of
using clinical symptoms in determining the etiology of
ILI. We also detected a small proportion of asymptomatic
individuals who tested positive for the various viruses
(Table 2). These could represent carriage without infec-
tion or subclinical/asymptomatic infections during pe-
riods of virus circulation.
Although ILI is widely used to identify influenza, the
traditional definition would have picked up only 69% of
influenza infections (except untyped FLU-A) that were
identified as FRI. ADV infections also frequently fulfilled
the ILI definition (89.7% of ADV-B and 65.0% of ADV-
E), as did substantial fractions of CV, hMPV, and CoV.
Only 40.1% of viral mono-infections that met the ILI def-
inition were due to influenza. We found a fairly high sen-
sitivity (72.2%) of ILI for influenza, but a low specificity
(48.1%) in keeping with sensitivities of 55.4–86.8% and
specifities of 39.3–67% reported elsewhere [25,39,41,37].
Figure 2 Multivariate analysis comparing viruses among clinical features adjusted for age, smoking status. Age, smoking status and a
categorical predictor for viruses were included in the analysis before subsequently removing non-significant variables. Columns represent the
categorical predictor for viruses, and each row corresponds to a virus that was chosen as the reference group. The viruses included from the top
row to the bottom row are Influenza A(H1N1)pdm09 (FLU-A(H1N1)pdm09), Influenza A(H3N2) (FLU-A(H3N2)), Influenza A(unknown type) (FLU-A
(unknown), Influenza B (FLU-B), Coxsackie virus (CV), Enterovirus (EV), Adenovirus E (ADV-E), ADV-B, Coronavirus OC43 (CoV-OC43), CoV-NL63,
CoV-229E, Human Metapneumovirus (hMPV) and Parainfluenza 3 (hPIV-3). Color cells represent variables that are significant at the 5% level, and
the thickness of the cell wall represents the p-value (thin means 0.01 < p < 0.05; medium, 0.001 < p < 0.01; and thick, p < 0.001). The odds ratios
are encoded by colors where a red cell indicates an odds ratio > 1; and blue otherwise. For example, for a sore throat, FLU-A(unknown), FLU-B,
CV, RV, ADV-E, CoV-OC43 and CoV-NL63 have more of the sore throat than IFLU-A(H1N1)pdm09 indicated by the red cells in the row for FLU-A
(H1N1)pdm09 and corresponding columns.
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PPV of ILI was low (40.1%) compared to other studies
(77.6–79.0%) likely because these studies were conducted
during influenza seasons. This is supported by the higher
NPV (69.3%) compared to other studies (48.9–55.0%)
[25,39,41,37]. Two tropical studies [14,25] also report low
PPV of 21.0–37% and high NPV of 81–90.0%.
ADV are as likely as influenza viruses to present with
fever and tend to be captured by the ILI definition. How-
ever, they are more likely to present with cough and sore-
throat than influenza. It may be possible to differentiate
ADV and influenza infection based on rhinorrhea and
other symptoms. This could be useful in surveillance and
clinical management, especially when deliberating whether
to start antivirals. Early etiologic diagnosis of influenza has
been shown to be cost effective [42] with reduced anti-
biotic use and may reduce complications with early antivi-
rals. It may be possible to combine a clinical diagnostic
model with rapid testing to achieve these goals.
Limitations
The analysis was limited to viral mono-infections and fu-
ture studies should explore co-infections and bacterial
infections. This study involved predominantly young adult
males, and results may not be generalizable to the overall
population, necessitating further studies among various
age groups and gender. There were also less recruits
amongst controls than amongst other groups, and this
would be an important consideration when comparing the
two groups in the future. Finally, the actual clinical impact
of differentiating between various viral etiological agents
may be limited, and we could not determine the relative
severity of symptoms other than fever.
Conclusion
Our study highlights the varied etiology for FRI and ILI
in the tropical setting – influenza and ADV and CV were
all common. Influenza and ADVs tend to present with
higher fever, and vaccination should be considered. The
utility of ILI for tropical surveillance of influenza needs
to be reviewed given the low PPV and high NPV com-
pared to temperate regions. The surveillance system has
enabled the Singapore military to understand the etio-
logic agents affecting servicemen, hence implementing
and evaluating controls measures such as vaccination.
Figure 3 Correlation of Symptoms and Signs Across all Viruses. Clinical signs or symptoms are listed by average frequency from the most to
the least. Binomial test is used to assess the discrepancy between the observed proportion of symptom pairs and the expected proportion of
symptom pairs which is the product of the two marginal distributions by assuming symptoms develop independently. Color cells represent
differences that are significant at the 5% level, and the thickness of the cell wall represents the p-value (thin means 0.01 < p < 0.05; medium,
0.001 < p < 0.01; and thick, p < 0.001). The excess probability encoded by colors measures the effect size. If the observed proportion is lower than
the expected proportion, the cell will be shaded by blue color, and red color otherwise.
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